Because they target multiple pathways involved in metabolism, GLP-1 agonists could become multi-functional therapies that provide comprehensive health benefits
population currently taking them
In addition, the use of GLP-1 RAs has significantly reduced the risk of mortality, MACE, and MAKE in patients requiring metformin or insulin therapy, suggesting the cost-effectiveness of GLP-1 RAs in these high-risk patients 41
Yes, Z79.4 is a billable/specific ICD-10-CM code that can be used for reimbursement purposes as either a primary or secondary diagnosis
Relevant R packages included coxphf (version 1.13.4) 116118 for Firth-corrected Cox proportional hazards models, MatchIt (version 4.7.0) 119,120 for propensity score matching, and survival (version 3.83) 121,122 for Cox proportional hazards models
4B2), the learning curve has already reached a plateau, suggesting that increasing the sample size would not improve model performance